Use of the dilute Russell viper venom time (dRVVT): Its importance and pitfalls

Journal of Autoimmunity

Volumn 15, Issue 2, 2000, Pages 173-178

  Triplett, Douglas A ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Midwest Hemostasis/Thrombosis Lab   (United States)

Author keywords

Laboratory testing; Russell viper

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CARDIOLIPIN ANTIBODY; FIBRIN DEGRADATION PRODUCT; LUPUS ANTICOAGULANT; PARAPROTEIN; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANTIBODY DETECTION; CLASSIFICATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DILUTE RUSSELL VIPER VENOM TIME; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; THROMBOPHILIA; THROMBOSIS;

EID: 0033834036     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0414     Document Type: Conference Paper

References (33)

1. Lupus anticoagulants: Misnomer, paradox, riddle, epiphenomenon
2. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders
3. A survey of 215 non-hemophilic patients with inhibitors to factor VIII
4. Management of hemophilia patients with inhibitors
5. Antiprothrombin antibodies: Detection and clinical significance in the antiphospholipid syndrome
6. Anti-prothrombin antibodies and the lupus anticoagulant
7. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors
8. Incoagulability of the blood in systemic lupus erythematosus. A case due to hypoprothrombinemia and a circulating anticoagulant
9. Antiprothrombin antibodies and their relation with thrombosis and lupus anticoagulants
10. Many faces of lupus anticoagulants
11. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants
12. Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance
13. Thrombosis, abortions, cerebral disease and the lupus anticoagulant
14. 2 glycoprotein I-dependent lupus anticoagulants
15. Role of phosphatidylethanolamine in inhibition of activated protein C activity by antiphospholipid antibodies
16. The pathogenesis of the antiphospholipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia
17. Criteria for the diagnosis of lupus anticoagulants: An update
18. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification
19. Laboratory diagnosis of lupus inhibitors. A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure
20. A simplified dRVVT for the diagnosis of lupus anticoagulant
21. Confirmatory reagent for the diagnosis of lupus anticoagulant
22. Studies on phospholipids in the action of a lupus coagulation inhibitor
23. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
24. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulants show marked differences in performance between photo-optical and mechanical coagulometers
25. 11 phases necessary?
26. (on behalf of U.K. National External Quality Assessment scheme of Blood Coagulation). Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEWAS) for blood coagulation
27. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants
28. Use of a simplified dilute Russell's viper venom time (dRVVT) confirms heterogeneity among 'lupus anticoagulants'
29. Evaluation of dilute Russell viper venom time (dRVVT) kits
30. Analysis of Russell viper venom (RVV) by SDS-PAGE
31. The textarin/ecarin ratio: A confirmatory test for lupus anticoagulants
32. Comparison between standard and new tests for diagnosis of the lupus anticoagulants
33. A comparison of different test systems in the diagnosis of lupus anticoagulants